Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

30.19
Delayed Data
As of 4:03pm ET
 +0.34 / +1.14%
Today’s Change
26.97
Today|||52-Week Range
34.88
-11.08%
Year-to-Date
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016
4:24pm / MotleyFool.com - Paid Partner Content
Post-Brexit Analysis: Should Investors Buy or Sell Biopharma?
Jun 24 / MotleyFool.com - Paid Partner Content
ACADIA Pharmaceuticals Inc.'s Shareholders Are Having a Crazy Year. Here's Why
Jun 28 / MotleyFool.com - Paid Partner Content
AstraZeneca Nasal Spray Flu Vaccine To be Hit By ACIP Vote
Jun 23 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Moving On Heavy Pre-Market Trading
Jun 28 / TheStreet.com - Paid Partner Content
7 Pharmaceutical Stocks With Dividends Yielding More Than 3%
Jun 21 / MotleyFool.com - Paid Partner Content
Frontrunning: June 28
Jun 28 / Investing Channel - Paid Partner Content
This New Class Of Medicine Could Reshape Diabetes Treatment
Jun 20 / MotleyFool.com - Paid Partner Content
The Brexit Vote Is Crushing These 3 Clinical-Stage Biotech Stocks
Jun 24 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close29.85
Today’s open29.63
Day’s range29.59 - 30.24
Volume5,627,490
Average volume (3 months)4,405,149
Market cap$75.5B
Dividend yield4.64%
Data as of 4:03pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-6.63%
Earnings growth (next 5 years)+4.34%
Revenue growth (last year)-5.11%
P/E ratio26.1
Price/Sales3.48
Price/Book4.08

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-0.18-0.18%
LLYEli Lilly and Co+0.60+0.77%
AGNAllergan+0.54+0.23%
ABTAbbott Laboratories+0.74+1.92%
Data as of 4:14pm ET, 06/30/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.51
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts

Partner Offers

Search for Jobs